Knowledgebase

Electromagnetic hypersensitivity

EMR Australia - Friday, January 29, 2016

Recent studies shed new insights on the condition of electromagnetic hypersensitivity (EHS).

Diagnosis and treatment

A group of 17 scientists from six nations has produced the EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses’. 1

Their paper reports the results of Professor Belpomme’s study on 1200 people with EHS and/or multiple chemical sensitivity (MCS). ‘Both EHS and MCS appear to paint a common picture of inflammation-related hyper-histaminemia, oxidative stress, autoimmune response and BBB [blood-brain-barrier] opening, and a deficit in melatonin excretion.’

As a first step, the authors recommend that sufferers measure fields at home and work and take action to reduce their exposure.

The authors also recommend a number of diagnostic tests as well as treatments, including oxidation, treating intestinal problems, improving nutrition, detoxification, improving mitochondrial function, reducing inflammation, sauna, exposure to natural light, oxygen therapy, exercise, drinking good quality water and appropriate dental care.

EHS perspective

The Swedish government classifies EHS as a ‘functional impairment’ - that is, a difficulty that limits the sufferer’s ability to engage in certain essential activities of life.2 This means that sufferers are not ‘seen as patients but citizens reacting to an inferior environment,’ said author, Professor Olle Johansson of Karolinska Institute. As a result of this approach, sufferers are not subjected to a battery of diagnostic tests and are not prescribed psychiatric treatments—as is recommended in many countries, including Australia.

The Swedish approach to EHS also enables sufferers to obtain economic support and legal protection.

In his paper, Professor Johansson describes the results of his research which showed that EHS people exposed to electromagnetic radiation had skin damage consistent with other forms of radiation exposure. Specifically, he found changes in the numbers and behaviours of mast cells, which are involved in pain, itching, edema and erythema— symptoms that are reported by many EHS sufferers.

EHS is not a nocebo effect

No, electromagnetic hypersensitivity is not a psychological (nocebo) effect, says M Dieudonné from France. After interviewing 40 people claiming to have EHS, Dr Dieudonné determined that symptoms appeared before people began questioning the effects of electromagnetic fields on their health—and not as a result of their negative perceptions about technology.

1. Belyaev, I et al, ‘EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses,’ Rev Environ Health, 30 (4):337-71, 2015.

2. Johansson, O, ‘Electrohypersensitivity: a functional impairment due to an inaccessible environment’, Rev Environ Health, 30(4):311-21, 2015.

3. Dieudonné, M, ‘Does electromagnetic hypersensitivity originate from nocebo responses? Indications from a qualitative study’, Bioelectromagnetics 37(1), 14-24,


About The Author - Lyn McLean is a consumer advocate, author and educator and has been monitoring and writing on the subject of electromagnetic radiation (EMR) for over 20 years. She is the director of EMR Australia.


Follow on Feedly follow us in feedly


Trackback Link
http://www.emraustralia.com.au/BlogRetrieve.aspx?BlogID=419&PostID=620973&A=Trackback
Trackbacks
Post has no trackbacks.

Recent Posts

Categories

Tags

A. Garcia Professor Michael Berk Venice Resolution Prof Andrew Marino Dr Priyanka Bandara Dr James Suckling Dr Stephen Solomon Dr Martin Pall Ken Karipidis Dr Louis Slesin Dr Cornelia Waldmann-Selsam Dr Ronald Powell Associate Professor Ray Kearney OAM Sydney Council Phone Tower Forum Dr Lisa Nagy Dr Lennart Hardell Prof Olle Johansson Jim Phillips Professor Hugo Lagercrantz Cindy Sage Professor Anthony Miller Dr Fernando Saravi Dr. Masayuki Tatemichi Professor Martin Pall Dr Dieudonné E Lopez-Martin Brett Moule Dr William Rea Dr Magda Havas WHO Professor Rodney Croft Dr Jacquinta Lee Vijayalaxmi and Maria Scarfi Dr James Oschman Dr Mary Redmayne Lennart Hardell Dr Ron Overberg ARPANSA RF Standard Dr De-Kun Li Dr Kenneth Foster Dr Igor Belyaev Dr Siegal Sadetzki Dr. Neil Cherry Dr Christine Aschermann John Cherry Dr S Mortazavi Salzburg Resolution IAFF Dr Maryanne Demasi Dr Olga Naidenko Dr Hugh Taylor Michael Carlberg Dr Markus Kern Stewart Committee Reports Professor Bruce Armstrong Frank Drews US Senate Hearing Prof Trevor Marshall Dr Lawrence Anukam Dr Dominique Belpomme Dr David Carpenter Dr Michael Kundi Dr John Dockerty Dr Christopher Portier Dr Devra Davis David Suzuki Paul Wentworth SCENIHR Report Professor Belpomme Michael Dolan Dr Jean Monroe Grant Brecht Dr Don Masich Alasdair Phillips Dr Arpad Szallasi (MD) Catalyst Ohio State University Specific Absorption Rate (SARs) Dr Gilbert de Paula (MD) Dr Asad Rahmani Frank Clegg Dr. Henry Lai John Patterson Dr, Louis, Slesin Dr Cyril Smith T Abelin Dr Larry Marshall Mr Gary Melik SAM Model Anne Silk Dr Dariuz Leszczynski Kaspersky Lab Dr Stephanie McCarter (MD) Dr Linda Erdreich Essex University Study Dennis J Kucinich Mona Nilsson

Archive

SuMoTuWeThFrSa
    123
45678910
11121314151617
18192021222324
25262728293031

EMR Australia © 2017. All Rights Reserved. Terms & Conditions | Privacy | Sitemap | Adobe Business Catalyst Sydney